Stoke Therapeutics Stock Options
| STOK Stock | USD 12.81 1.38 12.07% |
Stoke Therapeutics' latest option contracts expiring on 2024-12-20 are carrying combined implied volatility of 1.47 with a put-to-call open interest ratio of 0.14 over 4 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-12-20. The total put volume is at 11.0, with calls trading at the volume of 11.0. This yields a 3.67 put-to-call volume ratio.
Open Interest Against 2024-12-20 Option Contracts
2024-12-20
The chart above shows Stoke Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Stoke Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Stoke Therapeutics' option, there is no secondary market available for investors to trade.
Stoke Therapeutics' option chain provides insight into all available option contracts written on Stoke Therapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Stoke Therapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Stoke option contract.
In The Money vs. Out of Money Option Contracts on Stoke Therapeutics
Analyzing Stoke Therapeutics' in-the-money options over time can help investors to take a profitable long position in Stoke Therapeutics regardless of its overall volatility. This is especially true when Stoke Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Stoke Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Stoke Therapeutics' stock while costing only a fraction of its price.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Stoke Current Options Market Mood
Stoke Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Stoke Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Stoke Therapeutics' options investors are not very successful. Stoke Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Stoke contract
Base on the Rule 16, the options market is currently suggesting that Stoke Therapeutics will have an average daily up or down price movement of about 0.0919% per day over the life of the 2024-12-20 option contract. With Stoke Therapeutics trading at USD 12.81, that is roughly USD 0.0118. If you think that the market is fully incorporating Stoke Therapeutics' daily price movement you should consider buying Stoke Therapeutics options at the current volatility level of 1.47%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Stoke |
Purchasing Stoke Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Stoke calls. Remember, the seller must deliver Stoke Therapeutics stock to the call owner when a call is exercised.
Stoke Therapeutics Option Chain
When Stoke Therapeutics' strike price is surpassing the current stock price, the option contract against Stoke Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Stoke Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Stoke. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Stoke. It also shows strike prices and maturity days for a Stoke Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | STOK Option Call 20-12-2024 12 | 19 | 2024-12-20 | 0.5 - 4.9 | 0.61 | Out |
Call | STOK Option Call 20-12-2024 15 | 90 | 2024-12-20 | 0.0 - 0.4 | 0.15 | Out |
Put | STOK Option Put 20-12-2024 12 | 13 | 2024-12-20 | 0.45 - 4.9 | 1.1 | In |
Put | STOK Option Put 20-12-2024 15 | 2 | 2024-12-20 | 0.0 - 0.0 | 3.4 | In |
Stoke Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Stoke Total Stockholder Equity
Total Stockholder Equity |
|
Stoke Therapeutics Corporate Management
| CPA CPA | Chief Officer | Profile | |
| Jonathan JD | Corporate Counsel | Profile | |
| Shamim MS | Senior Officer | Profile | |
| FACC MD | Chief Officer | Profile | |
| Joan Wood | Chief Officer | Profile | |
| Dawn Kalmar | Chief Officer | Profile | |
| Huw Nash | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.08) | Revenue Per Share 0.328 | Quarterly Revenue Growth 0.479 | Return On Assets (0.28) | Return On Equity (0.52) |
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.